Učitavanje...

Recommended Therapeutic INR Range for Patients with Antiphospholipid Syndrome on Warfarin Anticoagulation: Is Moderate-Intensity (INR 2.0 - 3.0) or High-Intensity (INR 3.1 - 4.0) Better for Reducing Risk of Recurrent Thromboembolic Events?

Patients with antiphospholipid syndrome (APS) are at increased risk of recurrent thromboembolic events due to the pathology of the disease. While prolonged anticoagulation is the treatment of choice for patients with thrombosis, much debate remains about the optimum intensity of anticoagulation. Ant...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cureus
Glavni autori: Kim, Esther, Do, Tiffanie, Peacock, Katie, Takundwa, Prisca T
Format: Artigo
Jezik:Inglês
Izdano: Cureus 2016
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5045335/
https://ncbi.nlm.nih.gov/pubmed/27725921
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.765
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!